| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-07 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |